Statistical methods adjusted for demographics, disease severity, prior diabetes control, frailty, and a social deprivation score (a proxy for income and education)
( 10.1146/annurev.nutr.18.1.179) [DOI] [PubMed] [Google Scholar] Kodama H, Yamaguchi R, Fukuda J, Kasai H, Tanaka T.1997
Expected Benefits of Retatrutide Based on early evidence, potential benefits may include: Significant weight loss beyond existing GLP1 medications Improved appetite control Better metabolic health markers Potential benefits for prediabetes or type 2 diabetes Enhanced energy expenditure due to glucagon activity Once weekly dosing Final benefits will only be confirmed after Phase 3 trials
It can be familial and associated with other autoimmune diseases
If you're not approved, you're not charged at all
The microdose program uses sub-therapeutic doses primarily aimed at reducing food noise and cravings without the stronger appetite suppression of full doses